Keith Horspool reflects on the efforts that led the FDA to launch its pilot review program for novel excipients

Can we make clinical trials more accessible through virtual means?

Pharma needs to embrace the benefits of blockchain for improved transparency and agility in data management

The founder a UK manufacturer that serves pharma explains why his company switched to a bottom-up model

Sartorius shares its vision for better, faster, and cheaper bioprocessing.

Nominations are now open for The Medicine Maker 2023 Power List.

Can blood cancer care be improved to ensure that patients from minority groups receive equitable treatment?

It’s time for quality and manufacturing to go paperless, but how should a company go about digitization?

The women’s health treatment landscape is devoid of relevant options. What can pharma do to improve the situation?

ISCT speaks out after US court rules that stem cell therapy does not fall under FDA jurisdiction.